The Effects of DHA on Periodontitis
Completed · Phase 2 · Has a placebo group
Conditions studied: Periodontitis, Gingivitis, Inflammation
In brief
The purpose of this study is to determine whether docosahexaenoic acid (DHA) is effective in the treatment of periodontitis in adults.
Key facts
- Study ID
- NCT01976806
- Run by
- Beth Israel Deaconess Medical Center
- People needed
- 55
- Starts
- 2009-06-01
- Expected to finish
- 2011-09-01
- Last updated by the study team
- 2017-12-13
Who can join
Age: 40 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- age >40 years
- >20 natural teeth (excluding third molars)
- no orthodontic appliances
- periodontitis defined as >4 teeth with pocket probing depths >5 mm
You may not qualify if…
- pregnancy
- diabetes
- severe chronic diseases
- gastrointestinal bleeding
- uncontrolled chronic diseases
- autoimmune disorders
- conditions requiring antibiotic prophylaxis
- warfarin
- clopidogrel
- antimicrobial therapy within 30 days
- chronic use of non-steroidal anti-inflammatory drugs (other than aspirin)
- omega-3 fatty acid use within 6 months
- loose teeth
- painful teeth
- periodontal abscess
- pocket depths >10 mm in >1 tooth
- periodontal therapy within the past two years
- allergy to aspirin
- allergy to fish oil
- allergy to corn oil
- allergy to soybean oil
Where it is running
- Beth Israel Deaconess Medical Center — Boston, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.